Sugar identified as key to malaria parasite invasion

Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified a sugar in mosquitoes that allows the malaria-causing parasite, Plasmodium falciparum, to attach itself to the mosquito’s gut. Invasion of the midgut cell layer is an essential stage in the parasite’s lifecycle and in the transmission of malaria from mosquitoes to humans.

By reducing the level of the sugar, chondroitin sulfate, in the mosquito, the researchers prevented 95 percent of the parasites in the mosquito from attaching to the gut, thus blocking its development. The study is published in the online Early Edition of Proceedings of the National Academy of Sciences.

“This study provides significant new insights on how the parasite develops in the mosquito, complementing our earlier identification of another parasite midgut receptor that is a target for a transmission-blocking vaccine,” said Marcelo Jacobs-Lorena, PhD, senior author of the study and a professor in the Bloomberg School’s W. Harry Feinstone Department of Molecular Microbiology and Immunology. “This line of research could lead to new approaches for interfering with the spread of this deadly disease.”

To determine whether the parasite utilizes chondroitin glycosaminoglycans to invade the mosquito midgut cells, the researchers used a process known as RNA interference to inhibit production of a mosquito enzyme that is needed to produce chondroitin sulfate. With the sugar removed, parasite adhesion and midgut invasion were substantially decreased.

“Our study highlights the importance of sugars in parasite invasion of the mosquito gut. Previously, this phenomenon was only observed during parasite invasion of human tissues,” said Rhoel R. Dinglasan, PhD, MPH, lead author of the study and a postdoctoral fellow with the Malaria Research Institute. “It appears as if the parasite’s use of sugars as a strategy for cell invasion of tissues is similar in both man and mosquito. This may be an Achilles’ heel for the parasite, opening up the possibility of developing a vaccine that works against all stages of the parasite’s lifecycle.”

According to the researchers, many important questions must still be answered to determine if the glycosaminolgycan identified could be a potential antigen for a transmission-blocking vaccine. In a study published earlier this year in the PNAS, the JHMRI team identified a previously unknown mosquito antigen that the parasite uses for entry into the mosquito midgut, a critical step in the Plasmodium parasite’s development. The researchers produced an antibody that acts as a blanket to prevent the parasite from accessing the mosquito midgut antigen.

Their research showed that the antibodies were effective against multiple malaria parasites and could potentially provide the basis for a future ‘universal’ malaria transmission-blocking vaccine.

Source: Johns Hopkins University

Related stories:

New way to make malaria medicine also first step in finding new antibiotics
University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.
'Dodgy dossier' partly to blame for failure of war against malaria in the tropics
The war against malaria in tropical countries was fought and lost in the 20th Century on the basis of faulty intelligence, a 'dodgy dossier' which argued that the same methods used to tackle the disease in temperate countries would also work in the tropics.
Best way to treat malaria: Avoid using same drug for everyone, scientists say
(PhysOrg.com) -- A team of scientists employing a sophisticated computer model pioneered at Princeton University and Resources for the Future has found that many governments worldwide are recommending the wrong kind of malaria treatment.
Malaria researchers identify new mosquito virus
Researchers at the Johns Hopkins Bloomberg School of Public Health's Malaria Research Institute have identified a previously unknown virus that is infectious to Anopheles gambiae—the mosquito primarily responsible for transmitting malaria. According to the researchers, the discovered virus could one day be used to pass on new genetic information to An. gambiae mosquitoes as part of a strategy to control malaria, which kills over one million people worldwide each year. The study was published August 22 online in the peer-reviewed open access journal PLoS Pathogens.
Research exposes new target for malaria drugs
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
Identifying and disrupting key elements of malaria's 'sticky sack' adhesion strategy
Malaria is one of the most devastating diseases afflicting humanity. It infects and debilitates about 600 million people and kills up to three million people every year, mainly in the wet tropical regions of the world. Children and pregnant women are at particularly high risk.
Team finds key mechanism of DDT resistance in malarial mosquitoes
University of Illinois researchers have identified a key detoxifying protein in Anopheles mosquitoes that metabolizes DDT, a synthetic insecticide used since World War II to control the mosquitoes that spread malaria.
Researchers block transmission of malaria in animal tests
By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent new malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.

News discussion:

General Science news